Low Testosterone Drug Lawsuits Move Forward With Status Conference In “Low-T” Litigation


Low Testosterone Drug Lawsuits Pending In The U.S. District Court, Northern District Of Illinois Allege That Testosterone Makers Failed To Disclose The Serious Cardiovascular Risks Associated With Their Testosterone Products.

low-testosterone-drug-lawsuits-therapy-lawyerAs Southern Med Law attorneys continue to monitor the progress of the federal testosterone replacement therapy litigation, attorneys at the law firm note that a case management conference (CMO) is scheduled this week to discuss the 1,600 low testosterone drug lawsuits pending in the multidistrict litigation. The CMO is scheduled for 1:30 p.m. May 19 in Courtroom 2103 of the U.S. District Court, Northern District of Illinois where all federally filed testosterone lawsuits have been consolidated in a multidistrict litigation. According to the Northern Illinois federal court records, the testosterone replacement therapy lawsuits are filed on behalf of men who allege that they suffered stroke, heart attack, deep vein thrombosis, pulmonary embolism, and cardiac death allegedly due to using prescription testosterone drugs, such as AndroGel, Fortesta, and Testim. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

“Case management conferences are important to both parties as well as the court, particularly in litigation such as this one in which the testosterone lawsuits filings are continuing at a steady pace.” – Southern Med Law.

Southern Med Law has a unique understanding of the allegations made by the plaintiffs in the testosterone treatment therapy complaints because the law firm’s founder, Dr. François Blaudeau is both an attorney and practicing physician. Southern Med Law comprehends the medical and legal questions involved in testosterone treatment complaints which is what makes the law firm able to provide the aggressive and effective patient advocacy for those who believe they have been harmed by dangerous prescription drugs. If you or someone you love have been injured by testosterone therapy medication, please call Dr. Blaudeau at Southern Med Law to learn more about your legal rights today. Call the office directly at 205-547-5525 for a free, no obligation testosterone therapy lawsuit review or by filling out our online form on this site.

According to the law firm and the U.S. Food and Drug Administration (FDA), testosterone replacement therapy lawsuits filings began after the FDA announced in January 2014 that it was launching an investigation into the safety and effectiveness of all FDA-approved testosterone products, such as Androderm, Depo-Testosterone, and Axiron, that treat hypogonadism, which is low testosterone levels in men due to an underlying medical condition. The law firm adds that as a result of the FDA’s investigation, the federal agency in March 2015 ordered testosterone manufacturers to update the labels of their prescription testosterone products to include a warning of the potential increase in a patient’s risk of heart attack or stroke as a result of using testosterone medication. The FDA further ordered the label to reflect that testosterone treatment should be prescribed only to men whose low testosterone levels are directly caused by a disease or other medical condition, and not caused by aging. The federal regulatory agency also required testosterone manufacturers to conduct a “well-designed” clinical trial to address the question of whether an increased risk of heart attack or stroke exists among men who use testosterone products. (In Re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)
[fda.gov/Drugs/DrugSafety/ucm436259.htm, FDA, March 3, 2015]

Court records indicate that the defendants in the federal litigation in the Northern Illinois district court manufacture and market testosterone products. The low testosterone drug lawsuits allege that the defendants misrepresented their testosterone patches, gels, injections and creams as a safe and effective way to treat hypogonadism but they failed to disclose the serious cardiovascular and other health risks associated with their testosterone products. The testosterone litigation involves the following defendants:

  • AbbVie and Abbott Laboratories, which makes and
    markets AndroGel
  • Actavis, Inc. and Watson Pharmaceuticals
    manufacturers of AndroDerm
  • Auxilium Pharmaceuticals, Inc., which makes Testim
  • Endo Pharmaceuticals Inc., which manufactures
    Delatestryl and Fortesta
  • Eli Lilly and Company and Lilly USA LLC, makers of
  • Pfizer Inc. and its subsidiary, Pharmacia & Upjohn Co.,which makes and
    markets DepoTestosterone
  • (In re: Testosterone Replacement Therapy Product Liability Litigation –
    MDL No. 2545)

    About Southern Med Law

    Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation through Southern Med Law. His first-hand knowledge of medicine has made Southern Med Law an aggressive and effective legal advocate for those who were harmed due to dangerous and defective drugs. If you believe that you or a loved one was injured by testosterone products, please contact Southern Med Law today to learn more about your legal rights. You can arrange for a free, no obligation testosterone therapy lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.

This entry was posted in Southern Med Law | Article. Bookmark the permalink.